中南美的體外診斷市場:到2017年的預測

中南美的體外診斷市場:到2017年的預測 是由出版商GlobalData在2012年01月所出版的。 這份英文市場調查報告書包含Pages: 139 價格從美金3500起跳。

簡介

本報告提供中南美各國的體外診斷市場相關分析，整體市場結構與趨勢(收益總額·市場佔有率)為首，主要國家·部門單位詳細的市場趨勢，再加上主要企業簡介與市場佔有率，相關產品的開發平台評估，產業內的資本交易趨勢等的資訊彙整，為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 中南美的體外診斷市場

• 各各國市場的比較分析(2003∼2017年)
• 收益總額(2003∼2017年)
• 企業佔有率(2009∼2010年)

第4章 巴西的體外診斷市場

• 收益總額(2003∼2017年)
• 流通佔有率(2009∼2010年)
  • 臨床化學檢驗的流通佔有率(2009∼2010年)
  • 遺傳基因檢驗的流通佔有率(2009∼2010年)
  • 血液檢驗的流通佔有率(2009∼2010年)
  • 組織·細胞檢驗的流通佔有率(2009∼2010年)
  • 免疫化學檢查的流通佔有率(2009∼2010年)
  • 感染·免疫疾病檢驗的流通佔有率(2009∼2010年)
  • 微生物學培養檢驗的流通佔有率(2009∼2010年)
• 企業佔有率(2009∼2010年)
  • 體外診斷的企業佔有率(2009∼2010年)
  • 臨床化學檢驗的企業佔有率(2009∼2010年)
  • 遺傳基因檢驗的企業佔有率(2009∼2010年)
  • 血液檢驗的企業佔有率(2009∼2010年)
  • 組織·細胞檢驗的企業佔有率(2009∼2010年)
  • 免疫化學檢查的企業佔有率(2009∼2010年)
  • 感染·免疫疾病檢驗的企業佔有率(2009∼2010年)
  • 微生物學培養檢驗的企業佔有率(2009∼2010年)

第5章 阿根廷的體外診斷市場

• 收益總額(2003∼2017年)
• 流通佔有率(2009∼2010年)
  • 臨床化學檢驗的流通佔有率(2009∼2010年)
  • 遺傳基因檢驗的流通佔有率(2009∼2010年)
  • 血液檢驗的流通佔有率(2009∼2010年)
  • 組織·細胞檢驗的流通佔有率(2009∼2010年)
  • 免疫化學檢查的流通佔有率(2009∼2010年)
  • 感染·免疫疾病檢驗的流通佔有率(2009∼2010年)
  • 微生物學培養檢驗的流通佔有率(2009∼2010年)
• 企業佔有率(2009∼2010年)
  • 體外診斷的企業佔有率(2009∼2010年)
  • 臨床化學檢驗的企業佔有率(2009∼2010年)
  • 遺傳基因檢驗的企業佔有率(2009∼2010年)
  • 血液檢驗的企業佔有率(2009∼2010年)
  • 組織·細胞檢驗的企業佔有率(2009∼2010年)
  • 免疫化學檢查的企業佔有率(2009∼2010年)
  • 感染·免疫疾病檢驗的企業佔有率(2009∼2010年)
  • 微生物學培養檢驗的企業佔有率(2009∼2010年)

第6章 墨西哥的體外診斷市場

• 收益總額(2003∼2017年)
• 流通佔有率(2009∼2010年)
  • 臨床化學檢驗的流通佔有率(2009∼2010年)
  • 遺傳基因檢驗的流通佔有率(2009∼2010年)
  • 血液檢驗的流通佔有率(2009∼2010年)
  • 組織·細胞檢驗的流通佔有率(2009∼2010年)
  • 免疫化學檢查的流通佔有率(2009∼2010年)
  • 感染·免疫疾病檢驗的流通佔有率(2009∼2010年)
  • 微生物學培養檢驗的流通佔有率(2009∼2010年)
• 企業佔有率(2009∼2010年)
  • 體外診斷的企業佔有率(2009∼2010年)
  • 臨床化學檢驗的企業佔有率(2009∼2010年)
  • 遺傳基因檢驗的企業佔有率(2009∼2010年)
  • 血液檢驗的企業佔有率(2009∼2010年)
  • 組織·細胞檢驗的企業佔有率(2009∼2010年)
  • 免疫化學檢查的企業佔有率(2009∼2010年)
  • 感染·免疫疾病檢驗的企業佔有率(2009∼2010年)
  • 微生物學培養檢驗的企業佔有率(2009∼2010年)

第7章 中南美的體外診斷市場主要企業

• F. Hoffmann-La Roche Ltd.
• Siemens Healthcare
• Abbott Laboratories
• bioMerieux S.A.
• Bio-Rad Laboratories, Inc.
• Ortho-Clinical Diagnostics Inc.
• Beckman Coulter, Inc.
• 堀場製作所
• Becton, Dickinson and Company
• Sysmex
• Alere Inc.
• DiaSorin S.p.A
• Thermo Fisher Scientific Inc.
• Phadia AB
• Qiagen N.V.
• Gen-Probe Incorporated
• PerkinElmer, Inc.
• Mindray Medical International Limited
• Grifols, S.A.
• DIAGNOSTICA STAGO, Inc.

第8章 開發中產品

• 臨床化學檢驗市場開發中產品
• 免疫化學檢查市場開發中產品
• 血液檢驗的開發中產品
• 微生物學培養檢驗的開發中產品
• 感染·免疫疾病檢驗的開發中產品
• 組織·細胞檢驗的開發中產品
• 遺傳基因檢驗的開發中產品

第9章 財務交易環境

• 夥伴關係

第10章 附錄

圖表一覽

目錄

Abstract

South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture

Summary

GlobalData's new report, "South and Central America In Vitro Diagnostics Market Outlook to 2017- Clinical Chemistry Genetic Testing, Haematology, Histology and Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture" provides key market data on the South and Central America In Vitro Diagnostics market - Argentina, Brazil and Mexico. The report provides value (USD million) data for all the market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

• Countries covered include Argentina, Brazil and Mexico.
• Market size and company share data for In Vitro Diagnostics market categories - Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
• Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the market categories and countries.
• Global corporate-level profiles of key companies operating within the South and Central America In Vitro Diagnostics market..
• Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, bioMerieux S.A., Bio-Rad Laboratories, Inc., Ortho-Clinical Diagnostics Inc. and others.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the South and Central America In Vitro Diagnostics competitive landscape.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

TOC

1 Table of Contents

1 Table of Contents 2

• 1.1 List of Tables 7
• 1.2 List of Figures 9

2 Introduction 11

• 2.1 What is This Report About? 11

3 In Vitro Diagnostics in South and Central America 12

• 3.1 In Vitro Diagnostics Cross Country Comparison, USD Actual, 2003-2017 12
• 3.2 In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, 2003-2017 13
• 3.3 In Vitro Diagnostics, South and Central America, Company share (2009-2010) 21

4 In Vitro Diagnostics In Brazil 23

• 4.1 In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23
• 4.2 In Vitro Diagnostics, Brazil, Distribution Share (2009-2010) 29
• 4.2.1 Clinical Chemistry, Brazil, Distribution Share (2009-2010) 29
• 4.2.2 Genetic Testing , Brazil, Distribution Share (2009-2010) 29
• 4.2.3 Haematology , Brazil, Distribution Share (2009-2010) 30
• 4.2.4 Histology And Cytology , Brazil, Distribution Share (2009-2010) 30
• 4.2.5 Immuno Chemistry , Brazil, Distribution Share (2009-2010) 31
• 4.2.6 Infectious Immunology , Brazil, Distribution Share (2009-2010) 31
• 4.2.7 Microbiology Culture , Brazil, Distribution Share (2009-2010) 32
• 4.3 In Vitro Diagnostics, Brazil, Company share (2009-2010) 33
• 4.3.1 In Vitro Diagnostics, Brazil, Company share (2009-2010) 33
• 4.3.2 Clinical Chemistry, Brazil, Company share (2009-2010) 35
• 4.3.3 Genetic Testing, Brazil, Company share (2009-2010) 37
• 4.3.4 Haematology, Brazil, Company share (2009-2010) 39
• 4.3.5 Histology And Cytology, Brazil, Company share (2009-2010) 41
• 4.3.6 Immuno Chemistry, Brazil, Company share (2009-2010) 43
• 4.3.7 Infectious Immunology, Brazil, Company share (2009-2010) 45
• 4.3.8 Microbiology Culture, Brazil, Company share (2009-2010) 47

5 In Vitro Diagnostics In Argentina 48

• 5.1 In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, 2003-2017 48
• 5.2 In Vitro Diagnostics, Argentina, Distribution Share (2009-2010) 54
• 5.2.1 Clinical Chemistry , Argentina, Distribution Share (2009-2010) 54
• 5.2.2 Genetic Testing , Argentina, Distribution Share (2009-2010) 54
• 5.2.3 Haematology , Argentina, Distribution Share (2009-2010) 55
• 5.2.4 Histology and Cytology , Argentina, Distribution Share (2009-2010) 55
• 5.2.5 Immuno Chemistry , Argentina, Distribution Share (2009-2010) 56
• 5.2.6 Infectious Immunology , Argentina, Distribution Share (2009-2010) 56
• 5.2.7 Microbiology Culture , Argentina, Distribution Share (2009-2010) 57
• 5.3 In Vitro Diagnostics, Argentina, Company share (2009-2010) 58
• 5.3.1 In Vitro Diagnostics, Argentina, Company share (2009-2010) 58
• 5.3.2 Clinical Chemistry, Argentina, Company share (2009-2010) 60
• 5.3.3 Genetic Testing, Argentina, Company share (2009-2010) 62
• 5.3.4 Haematology, Argentina, Company share (2009-2010) 64
• 5.3.5 Histology and Cytology, Argentina, Company share (2009-2010) 66
• 5.3.6 Immuno Chemistry, Argentina, Company share (2009-2010) 68
• 5.3.7 Infectious Immunology, Argentina, Company share (2009-2010) 70
• 5.3.8 Microbiology Culture, Argentina, Company share (2009-2010) 72

6 In Vitro Diagnostics In Mexico 74

• 6.1 In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, 2003-2017 74
• 6.2 In Vitro Diagnostics, Mexico, Distribution Share (2009-2010) 80
• 6.2.1 Clinical Chemistry, Mexico, Distribution Share (2009-2010) 80
• 6.2.2 Genetic Testing, Mexico, Distribution Share (2009-2010) 80
• 6.2.3 Haematology, Mexico, Distribution Share (2009-2010) 81
• 6.2.4 Histology And Cytology, Mexico, Distribution Share (2009-2010) 81
• 6.2.5 Immuno Chemistry, Mexico, Distribution Share (2009-2010) 82
• 6.2.6 Infectious Immunology, Mexico, Distribution Share (2009-2010) 82
• 6.2.7 Microbiology Culture, Mexico, Distribution Share (2009-2010) 83
• 6.3 In Vitro Diagnostics, Mexico, Company Share (2009-2010) 84
• 6.3.1 In Vitro Diagnostics, Mexico, Company Share (2009-2010) 84
• 6.3.2 Clinical Chemistry, Mexico, Company Share (2009-2010) 86
• 6.3.3 Genetic Testing, Mexico, Company Share (2009-2010) 88
• 6.3.4 Haematology, Mexico, Company Share (2009-2010) 90
• 6.3.5 Histology And Cytology, Mexico, Company Share (2009-2010) 92
• 6.3.6 Immuno Chemistry, Mexico, Company Share (2009-2010) 94
• 6.3.7 Infectious Immunology, Mexico, Company Share (2009-2010) 96
• 6.3.8 Microbiology Culture, Mexico, Company Share (2009-2010) 98

7 Overview of Key Companies in South and Central America In Vitro Diagnostics Market 100

• 7.1 F. Hoffmann-La Roche Ltd. 100
• 7.1.1 Company Overview 100
• 7.1.2 Share in the South and Central America In Vitro Diagnostics Market 100
• 7.2 Siemens Healthcare 101
• 7.2.1 Company Overview 101
• 7.2.2 Share in the South and Central America In Vitro Diagnostics Market 101
• 7.3 Abbott Laboratories 102
• 7.3.1 Company Overview 102
• 7.3.2 Share in the South and Central America In Vitro Diagnostics Market 102
• 7.4 bioMerieux S.A. 103
• 7.4.1 Company Overview 103
• 7.4.2 Share in the South and Central America In Vitro Diagnostics Market 103
• 7.5 Bio-Rad Laboratories, Inc. 104
• 7.5.1 Company Overview 104
• 7.5.2 Share in the South and Central America In Vitro Diagnostics Market 104
• 7.6 Ortho-Clinical Diagnostics Inc. 105
• 7.6.1 Company Overview 105
• 7.6.2 Share in the South and Central America In Vitro Diagnostics Market 105
• 7.7 Beckman Coulter, Inc. 106
• 7.7.1 Company Overview 106
• 7.8 HORIBA, Ltd. 106
• 7.8.1 Company Overview 106
• 7.9 Becton, Dickinson and Company 107
• 7.9.1 Company Overview 107
• 7.10 Sysmex Corporation 107
• 7.10.1 Company Overview 107
• 7.11 Alere Inc. 107
• 7.11.1 Company Overview 107
• 7.12 DiaSorin S.p.A 108
• 7.12.1 Company Overview 108
• 7.13 Thermo Fisher Scientific Inc. 108
• 7.13.1 Company Overview 108
• 7.14 Phadia AB 108
• 7.14.1 Company Overview 108
• 7.15 Qiagen N.V. 109
• 7.15.1 Company Overview 109
• 7.16 Gen-Probe Incorporated 109
• 7.16.1 Company Overview 109
• 7.17 PerkinElmer, Inc. 110
• 7.17.1 Company Overview 110
• 7.18 Mindray Medical International Limited 110
• 7.18.1 Company Overview 110
• 7.19 Grifols, S.A. 111
• 7.19.1 Company Overview 111
• 7.20 DIAGNOSTICA STAGO, Inc. 111
• 7.20.1 Company Overview 111

8 In Vitro Diagnostics Market Pipeline Products 112

• 8.1 Clinical Chemisty Market Pipeline Products 112
• 8.2 Immuno Chemistry Market Pipeline Products 115
• 8.3 Haematology Market Pipeline Products 118
• 8.4 Infectious Immunology Market Pipeline Products 120
• 8.5 Microbiology Culture Market Pipeline Products 124
• 8.6 Histology and Cytology Market Pipeline Products 125
• 8.7 Genetic Testing Market Pipeline Products 126

9 Financial Deals Landscape 130

• 9.1 Partnerships 130
• 9.1.1 Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 130
• 9.1.2 Myriad Genetics Enters Into Licensing Agreement With Chronix Biomedical 131
• 9.1.3 AmStem Announces Co-Marketing Agreement With Histostem 132

10 Appendix 133

• 10.1 Definitions of Markets Covered in the Report 134
• 10.1.1 In Vitro Diagnostics 134
• 10.2 Research Methodology 136
• 10.3 Secondary Research 136
• 10.4 Primary Research 137
• 10.5 Models 137
• 10.6 Forecasts 138
• 10.7 Expert Panels 138
• 10.8 GlobalData Consulting 138
• 10.9 Currency Conversion 139
• 10.10 Contact Us 139
• 10.11 Disclaimer 139

List of Tables

1.1 List of Tables

• Table 1: In Vitro Diagnostics, Cross Country Comparison, USD Actual, 2003-2017 12
• Table 2: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, 2003-2017 14
• Table 3: In Vitro Diagnostics, South and Central America, Cross-Category Analysis, 2003-2017 16
• Table 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Historic, 2003-2010 18
• Table 5: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 20
• Table 6: In Vitro Diagnostics, South and Central America, Company share by Revenue ($m), USD Actual, 2009-2010 22
• Table 7: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 24
• Table 8: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 26
• Table 9: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 28
• Table 10: Clinical Chemistry, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 29
• Table 11: Genetic Testing, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 29
• Table 12: Haematology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30
• Table 13: Histology And Cytology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 30
• Table 14: Immuno Chemistry, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 31
• Table 15: Infectious Immunology, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 31
• Table 16: Microbiology Culture, Brazil, Distribution Share by Revenue ($m), USD Actual, 2009-2010 32
• Table 17: In Vitro Diagnostics, Brazil, Company share by Revenue ($m), USD Actual, 2009-2010 34
• Table 18: Clinical Chemistry, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 36
• Table 19: Genetic Testing, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 38
• Table 20: Haematology, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 40
• Table 21: Histology And Cytology, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 42
• Table 22: Immuno Chemistry, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 44
• Table 23: Infectious Immunology, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 46
• Table 24: Microbiology Culture, Brazil, Company share by Revenue ($m), USD Actual 2009-2010 47
• Table 25: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, 2003-2017 49
• Table 26: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Historic, 2003-2010 51
• Table 27: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 53
• Table 28: Clinical Chemistry, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 54
• Table 29: Genetic Testing, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 54
• Table 30: Haematology, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 55
• Table 31: Histology And Cytology, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 55
• Table 32: Immuno Chemistry, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 56
• Table 33: Infectious Immunology, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 56
• Table 34: Microbiology Culture, Argentina, Distribution Share by Revenue ($m), USD Actual, 2009-2010 57
• Table 35: In Vitro Diagnostics, Argentina, Company share by Revenue ($m), USD Actual, 2009-2010 59
• Table 36: Clinical Chemistry, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 61
• Table 37: Genetic Testing, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 63
• Table 38: Haematology, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 65
• Table 39: Histology And Cytology, Argentina, Company Share by Revenue ($m), USD Actual 2009-2010 67
• Table 40: Immuno Chemistry, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 69
• Table 41: Infectious Immunology, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 71
• Table 42: Microbiology Culture, Argentina, Company share by Revenue ($m), USD Actual 2009-2010 73
• Table 43: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, 2003-2017 75
• Table 44: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Historic, 2003-2010 77
• Table 45: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 79
• Table 46: Clinical Chemistry, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 80
• Table 47: Genetic Testing, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 80
• Table 48: Haematology, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 81
• Table 49: Histology And Cytology, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 81
• Table 50: Immuno Chemistry, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 82
• Table 51: Infectious Immunology, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 82
• Table 52: Microbiology Culture, Mexico, Distribution Share by Revenue ($m), USD Actual, 2009-2010 83
• Table 53: In Vitro Diagnostics, Mexico, Company Share by Revenue ($m), USD Actual, 2009-2010 85
• Table 54: Clinical Chemistry, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 87
• Table 55: Genetic Testing, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 89
• Table 56: Haematology, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 91
• Table 57: Histology And Cytology, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 93
• Table 58: Immuno Chemistry, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 95
• Table 59: Infectious Immunology, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 97
• Table 60: Microbiology Culture, Mexico, Company Share by Revenue ($m), USD Actual 2009-2010 99
• Table 61: Clinical Chemisty Market Pipeline Products 112
• Table 62: Immuno Chemistry Market Pipeline Products 115
• Table 63: Haematology Market Pipeline Products 118
• Table 64: Infectious Immunology Market Pipeline Products 120
• Table 65: Microbiology Culture Market Pipeline Products 124
• Table 66: Histology and Cytology Market Pipeline Products 125
• Table 67: Genetic Testing Market Pipeline Products 126
• Table 68: Enigma Diagnostics Enters Into Co-Development Agreement With GlaxoSmithKline 130
• Table 69: Myriad Genetics Enters Into Licensing Agreement With Chronix Biomedical 131
• Table 70: AmStem Announces Co-Marketing Agreement With Histostem 132
• Table 71: USD to Local Currency, South and Central America, Average Exchange Rate 2003-2010 139

List of Figures

1.2 List of Figures

• Figure 1: In Vitro Diagnostics, Cross Country Comparison , USD Actual, 2003-2017 12
• Figure 2: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, 2003-2017 13
• Figure 3: In Vitro Diagnostics, South and Central America, Cross-Category Analysis, 2003-2017 15
• Figure 4: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Historic, 2003-2010 17
• Figure 5: In Vitro Diagnostics, South and Central America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 19
• Figure 6: In Vitro Diagnostics, South and Central America, Company share (%), 2010 21
• Figure 7: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, 2003-2017 23
• Figure 8: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Historic, 2003-2010 25
• Figure 9: In Vitro Diagnostics, Brazil, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 27
• Figure 10: In Vitro Diagnostics, Brazil, Company share (%), 2010 33
• Figure 11: Clinical Chemistry, Brazil, Company share (%), 2010 35
• Figure 12: Genetic Testing, Brazil, Company share (%), 2010 37
• Figure 13: Haematology, Brazil, Company share (%), 2010 39
• Figure 14: Histology And Cytology, Brazil, Company share (%), 2010 41
• Figure 15: Immuno Chemistry, Brazil, Company share (%), 2010 43
• Figure 16: Infectious Immunology, Brazil, Company share (%), 2010 45
• Figure 17: Microbiology Culture, Brazil, Company share (%), 2010 47
• Figure 18: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, 2003-2017 48
• Figure 19: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Historic, 2003-2010 50
• Figure 20: In Vitro Diagnostics, Argentina, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 52
• Figure 21: In Vitro Diagnostics, Argentina, Company share (%), 2010 58
• Figure 22: Clinical Chemistry, Argentina, Company share (%), 2010 60
• Figure 23: Genetic Testing, Argentina, Company share (%), 2010 62
• Figure 24: Haematology, Argentina, Company share (%), 2010 64
• Figure 25: Histology And Cytology, Argentina, Company Share (%), 2010 66
• Figure 26: Immuno Chemistry, Argentina, Company share (%), 2010 68
• Figure 27: Infectious Immunology, Argentina, Company share (%), 2010 70
• Figure 28: Microbiology Culture, Argentina, Company share (%), 2010 72
• Figure 29: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, 2003-2017 74
• Figure 30: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Historic, 2003-2010 76
• Figure 31: In Vitro Diagnostics, Mexico, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 78
• Figure 32: In Vitro Diagnostics, Mexico, Company Share (%), 2010 84
• Figure 33: Clinical Chemistry, Mexico, Company Share (%), 2010 86
• Figure 34: Genetic Testing, Mexico, Company Share (%), 2010 88
• Figure 35: Haematology, Mexico, Company Share (%), 2010 90
• Figure 36: Histology And Cytology, Mexico, Company Share (%), 2010 92
• Figure 37: Immuno Chemistry, Mexico, Company Share (%), 2010 94
• Figure 38: Infectious Immunology, Mexico, Company Share (%), 2010 96
• Figure 39: Microbiology Culture, Mexico, Company Share (%), 2010 98
• Figure 40: F. Hoffmann-La Roche Ltd., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 100
• Figure 41: Siemens Healthcare, Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 101
• Figure 42: Abbott Laboratories, Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 102
• Figure 43: bioMerieux S.A., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 103
• Figure 44: Bio-Rad Laboratories, Inc., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 104
• Figure 45: Ortho-Clinical Diagnostics Inc., Company Share (%), South and Central America In Vitro Diagnostics Market, 2010 105

相關商品

體外診斷設備相關市場調查報告書

全球切片設備市場:開發平台分析，競爭環境，到2018年為止的市場預測
Biopsy Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
價格 : US $ 3995
出版日期 : 2012年04月

全球分子診斷市場:各國的設施·檢驗數量·銷售額預測
2012 World Molecular Diagnostics Market Overview: Facilities, Test Volumes, and Sales Forecasts by Country
價格 : US $ 1850
出版日期 : 2012年04月

全球微生物測試市場展望：成長機會及業務拓展策略
2012 Microbiology Testing Market Outlook: Growth Opportunities and Strategies
價格 : US $ 28700
出版日期 : 2012年04月

GlobalData發行的醫療設備相關市場調查報告書

全球先進型創傷管理市場:開發平台分析，競爭環境，到2018年為止的市場預測

Advanced Wound Management - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

價格 : US $ 3995

出版日期 : 2012年04月

臨床化學:全球性開發平台分析，競爭情形，到2018年為止的市場未來預測

Clinical Chemistry - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

價格 : US $ 3995

出版日期 : 2012年04月

免疫化學分析儀與檢查套件:全球性開發平台分析，競爭情形，到2018年為止的市場未來預測

Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

價格 : US $ 3995

出版日期 : 2012年04月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!